Zydus Cadila gets USFDA nod for Fluphenazine HCL Tablets

This medication is used to treat symptoms of a certain type of mental/mood condition (schizophrenia).

41
USFDA
Picture: Pixabay

Zydus Cadila has received final approval from the USFDA to market Fluphenazine Hydrochloride Tablets in the strengths of 1 mg, 2.5 mg, 5 mg, and 10 mg (US RLD: Prolixin Tablets).

This medication is used to treat symptoms of a certain type of mental/mood condition (schizophrenia).

Fluphenazine belongs to a class of medications called phenothiazines and is also referred to as a neuroleptic.

The drug will be manufactured at the group’s formulation manufacturing facility at the SEZ, Ahmedabad.

The group now has 318 approvals and has so far filed over 400 ANDAs since the commencement of the filing process in FY 2003-04.

Medicine
Picture: Pixabay

Other approvals:

Glenmark gets USFDA nod for Icatibant injection single-dose prefilled syringe

NATCO Pharma gets USFDA nod for Everolimus tablets

Natco Pharma gets USFDA nod for Lenalidomide capsules

Unichem Labs gets USFDA approval for Amitriptyline HCL Tablets

Alembic gets USFDA Final nod for Lurasidone HCL Tablets

Alembic gets USFDA nod for depression treatment drug


Also read:

Merck launches synthetic cholesterol product

Sun Pharma acquires trademarks of 3 diabetes drug from AstraZeneca

Draft guidelines issued for fee fixation for MBBS & PG courses

Govt constitutes National Council for Clinical Establishments

DCI issues advisory on holding examination by Dental colleges

Govt mandates deploying D Pharm, B Pharm & Pharm D in…

Subscribe for daily free updates on Telegram

Follow us on Facebook and Linkedin

For daily free updates on WhatsApp, click here

Enter your email address:

Delivered by FeedBurner